Inflammation Research

, Volume 59, Issue 6, pp 419–428 | Cite as

Effect of a matrix metalloproteinase-12 inhibitor, S-1, on allergic airway disease phenotypes in mice

  • Yingyan Yu
  • Yoshihiko Chiba
  • Hiroyasu Sakai
  • Miwa Misawa
Original Research Paper

Abstract

Objective

Matrix metalloproteinase-12 (MMP-12) has been reported to play an important role in chronic airway inflammatory diseases, but its detailed role in allergic airway disease is not well known. In this study, we investigated the expressions of MMP-12 and the effect of S-1, an MMP-12 inhibitor, in a mouse model of allergic airway inflammation.

Materials and methods

The expressions and activity of MMP-12 were measured by RT-PCR western blot and zymography, respectively. The locations in the airways of MMP-12 and elastin fiber were histologically studied. The mice were orally administered with S-1 during the period of antigen challenge. Bronchoalveolar lavage fluid (BALF) cells were counted, and the activity of MMP-12 in BALF was measured by zymography after the treatment with S-1.

Results

The allergen challenge model resulted in increased eosinophil number in BALF and damage to elastin fiber. Upregulation of MMP-12 was also found in the airways of challenged mice. The increased eosinophil number in the BALF after antigen challenge was inhibited by S-1.

Conclusion

These findings suggest that MMP-12 may play an important role in the eosinophil infiltration of the allergic airway.

Keywords

Matrix metalloproteinase-12 (MMP-12) MMP-9 S-1 Airway inflammation Allergic airway disease 

References

  1. 1.
    McCawley LJ, Matrisian LM. Matrix metalloproteinases: they’re not just for matrix anymore!. Curr Opin Cell Biol. 2001;13:534–40.CrossRefPubMedGoogle Scholar
  2. 2.
    Starcher BC. Elastin and the lung. Thorax. 1986;41:577–85.CrossRefPubMedGoogle Scholar
  3. 3.
    Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science. 1997;277:2002–4.CrossRefPubMedGoogle Scholar
  4. 4.
    Demedts IK, Morel-Montero A, Lebecque S, Pacheco Y, Cataldo D, Joos GF, et al. Elevated MMP-12 protein levels in induced sputum from patients with COPD. Thorax. 2006;61:196–201.CrossRefPubMedGoogle Scholar
  5. 5.
    Xie S, Issa R, Sukkar MB, Oltmanns U, Bhavsar PK, Papi A, et al. Induction and regulation of matrix metalloproteinase-12 in human airway smooth muscle cells. Respir Res. 2005;6:148.CrossRefPubMedGoogle Scholar
  6. 6.
    Nénan S, Boichot E, Lagente V, Bertrand CP. Macrophage elastase (MMP-12): a pro-inflammatory mediator? Mem Inst Oswaldo Cruz. 2005; Suppl 1:167–72.Google Scholar
  7. 7.
    Warner RL, Lukacs NW, Shapiro SD, Bhagarvathula N, Nerusu KC, Varani J, et al. Role of metalloelastase in a model of allergic lung responses induced by cockroach allergen. Am J Pathol. 2004;165:1921–30.PubMedGoogle Scholar
  8. 8.
    Lanone S, Zheng T, Zhu Z, Liu W, Lee CG, Ma B, et al. Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J Clin Invest. 2002;110:463–74.PubMedGoogle Scholar
  9. 9.
    Chiba Y, Yu Y, Sakai H, Misawa M. Increase in the expression of matrix metalloproteinase-12 in the airways of rats with allergic bronchial asthma. Biol Pharm Bull. 2007;30:318–23.CrossRefPubMedGoogle Scholar
  10. 10.
    Ko FW, Diba C, Roth M, McKay K, Johnson PR, Salome C, et al. A comparison of airway and serum matrix metalloproteinase-9 activity among normal subjects, asthmatic patients, and patients with asthmatic mucus hypersecretion. Chest. 2005;127:1919–27.CrossRefPubMedGoogle Scholar
  11. 11.
    Corry DB, Kiss A, Song LZ, Song L, Xu J, Lee SH, et al. Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines. FASEB J. 2004;18:995–7.PubMedGoogle Scholar
  12. 12.
    Kumagai K, Ohno I, Okada S, Ohkawara Y, Suzuki K, Shinya T, et al. Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. J Immunol. 1999;162:4212–9.PubMedGoogle Scholar
  13. 13.
    Maekawa R, Maki H, Wada T, Yoshida H, Nishida-Nishimoto K, Okamoto H, et al. Anti-metastatic efficacy and safety of MMI-166, a selective matrix metalloproteinase inhibitor. Clin Exp Metastasis. 2000;18:61–6.CrossRefPubMedGoogle Scholar
  14. 14.
    Tamura Y, Watanabe F, Nakatani T, Yasui K, Fuji M, Komurasaki T, et al. Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives. J Med Chem. 1998;41:640–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Curci JA, Liao S, Huffman MD, Shapiro SD, Thompson RW. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest. 1998;102:1900–10.CrossRefPubMedGoogle Scholar
  16. 16.
    Chiba Y, Kurotani R, Kusakabe T, Miura T, Link BW, Misawa M, et al. Uteroglobin-related protein 1 expression suppresses allergic airway inflammation in mice. Am J Respir Crit Care Med. 2006;173:958–64.CrossRefPubMedGoogle Scholar
  17. 17.
    Inoue K, Takano H, Yanagisawa R, Sakurai M, Ichinose T, Sadakane K, et al. Effects of nano particles on antigen-related airway inflammation in mice. Respir Res. 2005;6:106.CrossRefPubMedGoogle Scholar
  18. 18.
    Zhang RB, He QY, Yang RH, Lu BB, Liu YJ. Study on matrix metalloproteinase 1, 9, 12 polymorphisms and susceptibility to chronic obstructive pulmonary disease among Han nationality in northern China. Zhonghua Liu Xing Bing Xue Za Zhi. 2005;26:907–10.PubMedGoogle Scholar
  19. 19.
    Wang X, Inoue S, Gu J, Miyoshi E, Noda K, Li W, et al. Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice. Proc Natl Acad Sci USA. 2005;102:15791–6.CrossRefPubMedGoogle Scholar
  20. 20.
    Kato Y, Manabe T, Tanaka Y, Mochizuki H. Effect of an orally active Th1/Th2 balance modulator, M50367, on IgE production, eosinophilia, and airway hyperresponsiveness in mice. J Immunol. 1999;162:7470–9.PubMedGoogle Scholar
  21. 21.
    Shapiro SD, Kobayashi DK, Ley TJ. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem. 1993;268:23824–9.PubMedGoogle Scholar
  22. 22.
    Pouladi MA, Robbins CS, Swirski FK, Cundall M, McKenzie AN, Jordana M, et al. Interleukin-13-dependent expression of matrix metalloproteinase-12 is required for the development of airway eosinophilia in mice. Am J Respir Cell Mol Biol. 2004;30:84–90.CrossRefPubMedGoogle Scholar
  23. 23.
    Lavigne MC, Thakker P, Gunn J, Wong A, Miyashiro JS, Wasserman AM, et al. Human bronchial epithelial cells express and secrete MMP-12. Biochem Biophys Res Commun. 2004;2:534–46.CrossRefGoogle Scholar
  24. 24.
    Feinberg MW, Jain MK, Werner F, Sibinga NE, Wiesel P, Wang H, et al. Transforming growth factor-beta 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages. J Biol Chem. 2000;275:25766–73.CrossRefPubMedGoogle Scholar
  25. 25.
    Kips JC, Pauwels RA. Are cytokines responsible for the asthmatic state of the airways? Monaldi Arch Chest Dis. 1996;51:223–7.PubMedGoogle Scholar
  26. 26.
    Uller L, Persson CG, Erjefält JS. Resolution of airway disease: removal of inflammatory cells through apoptosis, egression or both? Trends Pharmacol Sci. 2006;27:461–6.CrossRefPubMedGoogle Scholar
  27. 27.
    Suzuki R, Miyazaki Y, Takagi K, Torii K, Taniguchi H. Matrix metalloproteinases in the pathogenesis of asthma and COPD: implications for therapy. Treat Respir Med. 2004;3:17–27.CrossRefPubMedGoogle Scholar
  28. 28.
    Nénan S, Planquois JM, Hitier S, Berna P, Boichot E, Lagente V, et al. Modulation of MMP-12-induced pulmonary inflammation in mice by rolipram, dexamethasone and marimastat. Fundam Clin Pharmacol. 2004;18:S109.Google Scholar
  29. 29.
    Vaalamo M, Kariniemi AL, Shapiro SD, Saarialho-Kere U. Enhanced expression of human metalloelastase (MMP-12) in cutaneous granulomas and macrophage migration. J Invest Dermatol. 1999;112:499–505.CrossRefPubMedGoogle Scholar
  30. 30.
    Cundall M, Sun Y, Miranda C, Trudeau JB, Barnes S, Wenzel SE. Neutrophil-derived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids. J Allergy Clin Immunol. 2003;112:1064–71.CrossRefPubMedGoogle Scholar
  31. 31.
    DiScipio RG, Schraufstatter IU. The role of the complement anaphylatoxins in the recruitment of eosinophils. Int Immunopharmacol. 2007;7:1909–23.CrossRefPubMedGoogle Scholar
  32. 32.
    Pégorier S, Wagner LA, Gleich GJ, Pretolani M. Eosinophil-derived cationic proteins activate the synthesis of remodeling factors by airway epithelial cells. J Immunol. 2006;177:4861–9.PubMedGoogle Scholar
  33. 33.
    Lantz MS, Ciborowski P. Zymographic techniques for detection and characterization of microbial proteases. Methods Enzymol. 1994;235:563–94.CrossRefPubMedGoogle Scholar
  34. 34.
    Gottlieb DJ, Stone PJ, Sparrow D, Gale ME, Weiss ST, Snider GL, et al. Urinary desmosine excretion in smokers with and without rapid decline of lung function: the Normative Aging Study. Am J Respir Crit Care Med. 1996;154:1290–5.PubMedGoogle Scholar
  35. 35.
    Rosenbloom J, Abrams WR, Mecham R. Extracellular matrix 4: the elastic fiber. FASEB J. 1993;7:1208–18.PubMedGoogle Scholar
  36. 36.
    Pham DN, Chu HW, Martin RJ, Kraft M. Increased matrix metalloproteinase-9 with elastolysis in nocturnal asthma. Ann Allergy Asthma Immunol. 2003;90:72–8.CrossRefPubMedGoogle Scholar
  37. 37.
    Xisto DG, Farias LL, Ferreira HC, Picanço MR, Amitrano D, Lapa E, et al. Lung parenchyma remodeling in a murine model of chronic allergic inflammation. Am J Respir Crit Care Med. 2005;71:829–37.CrossRefGoogle Scholar
  38. 38.
    Mann BS, Chung KF. Blood neutrophil activation markers in severe asthma: lack of inhibition by prednisolone therapy. Respir Res. 2006;7:59.CrossRefPubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag, Basel/Switzerland 2010

Authors and Affiliations

  • Yingyan Yu
    • 1
  • Yoshihiko Chiba
    • 1
  • Hiroyasu Sakai
    • 1
  • Miwa Misawa
    • 1
  1. 1.Department of Pharmacology, School of PharmacyHoshi UniversityTokyoJapan

Personalised recommendations